Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design

REFERENCES

• Baral S., Sifakis F., Cleghorn F., Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries, 2000–2006: A systematic review. PLoS Med 2007; 4: e339
   PubMed Web of Science ®Google Scholar
• Wolitski R. J., Parsons J. T., Gomez C. A. Prevention with HIV-seropositive men who have sex with men: Lessons from the Seropositive Urban Men's Study (SUMS) and the Seropositive Urban Men's Intervention Trial (SUMIT). J Acquir Immune Defic Syn 2004; 37(Suppl 2)S101–S109
   PubMed Web of Science ®Google Scholar
• Bezemer D., de Wolf F., Boerlijst M. C., van Sighem A., Hollingsworth T. D., Prins M., Geskus R. B., Gras L., Coutinho R. A., Fraser C. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008; 22: 1071–1077
   PubMed Web of Science ®Google Scholar
• Ortiz M. R. HIV, AIDS, and sexuality. Nurs Clin North Am 2007; 42: 639–653; viii
   Google Scholar
• Duerr A., Wasserheit J. N., Corey L. HIV vaccines: New frontiers in vaccine development. Clin Infect Dis 2006; 43: 500–511
   PubMed Web of Science ®Google Scholar
• Girard M. P., Osmanov S. K., Kieny M. P. A review of vaccine research and development: The human immunodeficiency virus (HIV). Vaccine 2006; 24: 4062–4081
   PubMed Web of Science ®Google Scholar
• Stevceva L., Strober W. Mucosal HIV vaccines: Where are we now?. Curr HIV Res 2004; 2: 1–10
   PubMed Web of Science ®Google Scholar
• Denning P. H., Campsmith M. L. Unprotected anal intercourse among HIV-positive men who have a steady male sex partner with negative or unknown HIV serostatus. Am J Public Health 2005; 95: 152–158
   PubMed Web of Science ®Google Scholar
• Carballo-Dieguez A., Bauermeister J. A., Ventuneac A., Dolezal C., Balan I., Remien R. H. The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: Implications for rectal microbicides. AIDS Behav 2007, DOI 10.1007/s10461-007-9301-0
   Google Scholar
• Hladik F., McElrath M. J. Setting the stage: Host invasion by HIV. Nat Rev Immunol 2008; 8: 447–457
   PubMed Web of Science ®Google Scholar
• Phillips D. M., Sudol K. M., Taylor C. L., Guichard L., Elsen R., Maguire R. A. Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception 2004; 70: 107–110
   PubMed Web of Science ®Google Scholar
• Honey K. Microbicide trial screeches to a halt. J Clin Invest 2007; 117: 1116
   Google Scholar
• Tao W., Richards C., Hamer D. Enhancement of HIV infection by cellulose sulfate. AIDS Res Hum Retroviruses 2008; 24: 925–929
   PubMed Web of Science ®Google Scholar
• Freeman E. E., Weiss H. A., Glynn J. R., Cross P. L., Whitworth J. A., Hayes R. J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73–83
   PubMed Web of Science ®Google Scholar
• Kaul R., Pettengell C., Sheth P. M., Sunderji S., Biringer A., MacDonald K., Walmsley S., Rebbapragada A. The genital tract immune milieu: An important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 2008; 77: 32–40
   PubMed Web of Science ®Google Scholar
• Reynolds S. J., Risbud A. R., Shepherd M. E., Rompalo A. M., Ghate M. V., Godbole S. V., Joshi S. N., Divekar A. D., Gangakhedkar R. R., Bollinger R. C., Mehendale S. M. High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India. Sex Transm Infect 2006; 82: 121–126
   PubMed Web of Science ®Google Scholar
• Buchacz K., Klausner J. D., Kerndt P. R., Shouse R. L., Onorato I., McElroy P. D., Schwendemann J., Tambe P. B., Allen M., Coye F., Kent C., Park M. N., Hawkins K., Samoff E., Brooks J. T. HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syn 2008; 47: 234–240
   PubMedGoogle Scholar
• Klotman M. E., Rapista A., Teleshova N., Micsenyi A., Jarvis G. A., Lu W., Porter E., Chang T. L. Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: Role in enhanced transmission. J Immunol 2008; 180: 6176–6185
   Google Scholar
• Yamada R., Sasagawa T., Kirumbi L. W., Kingoro A., Karanja D. K., Kiptoo M., Nakitare G. W., Ichimura H., Inoue M. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol 2008; 80: 847–855
   PubMed Web of Science ®Google Scholar
• Myer L., Wright T. C., Jr., Denny L., Kuhn L. Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis 2006; 33: 683–687
   PubMed Web of Science ®Google Scholar
• Hirbod T., Broliden K. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women. J Intern Med 2007; 262: 44–58
   PubMedGoogle Scholar
• Haynes B. F., Shattock R. J. Critical issues in mucosal immunity for HIV-1 vaccine development. J Allergy Clin Immunol 2008; 122: 3–9
   Google Scholar
• Patterson B. K., Landay A., Siegel J. N., Flener Z., Pessis D., Chaviano A., Bailey R. C. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 2002; 161: 867–873
   PubMed Web of Science ®Google Scholar
• Donoval B. A., Landay A. L., Moses S., Agot K., Ndinya-Achola J. O., Nyagaya E. A., MacLean I., Bailey R. C. HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 2006; 125: 386–391
   Web of Science ®Google Scholar
• Miller C. J., Alexander N. J., Sutjipto S., Lackner A. A., Gettie A., Hendrickx A. G., Lowenstine L. J., Jennings M., Marx P. A. Genital mucosal transmission of simian immunodeficiency virus: Animal model for heterosexual transmission of human immunodeficiency virus. J Virol 1989; 63: 4277–4284
   PubMedGoogle Scholar
• Shaw J. L., Smith C. R., Diamandis E. P. Proteomic analysis of human cervico-vaginal fluid. J Proteome Res 2007; 6: 2859–2865
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P., Johansen F. E. Mucosal B cells: Phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005; 206: 32–63
   PubMed Web of Science ®Google Scholar
• Wershil B. K., Furuta G. T. 4. Gastrointestinal mucosal immunity. J Allergy Clin Immunol 2008; 121: S380–S383
   PubMed Web of Science ®Google Scholar
• Khanvilkar K., Donovan M. D., Flanagan D. R. Drug transfer through mucus. Adv Drug Deliv Rev 2001; 48: 173–193
   PubMed Web of Science ®Google Scholar
• Neutra M. R., Kozlowski P. A. Mucosal vaccines: The promise and the challenge. Nat Rev Immunol 2006; 6: 148–158
   PubMed Web of Science ®Google Scholar
• Hu Q., Frank I., Williams V., Santos J. J., Watts P., Griffin G. E., Moore J. P., Pope M., Shattock R. J. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 2004; 199: 1065–1075
   PubMed Web of Science ®Google Scholar
• Zhang Z. Q., Wietgrefe S. W., Li Q., Shore M. D., Duan L., Reilly C., Lifson J. D., Haase A. T. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci USA 2004; 101: 5640–5645
   Web of Science ®Google Scholar
• Wilkinson J., Cunningham A. L. Mucosal transmission of HIV-1: First-stop dendritic cells. Curr Drug Targets 2006; 7: 1563–1569
   Google Scholar
• Hladik F., Sakchalathorn P., Ballweber L., Lentz G., Fialkow M., Eschenbach D., McElrath M. J. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26: 257–270
   PubMed Web of Science ®Google Scholar
• Kawamura T., Koyanagi Y., Nakamura Y., Ogawa Y., Yamashita A., Iwamoto T., Ito M., Blauvelt A., Shimada S. Significant virus replication in Langerhans cells following application of HIV to abraded skin: Relevance to occupational transmission of HIV. J Immunol 2008; 180: 3297–3304
   Google Scholar
• Miller H., Zhang J., Kuolee R., Patel G. B., Chen W. Intestinal M cells: The fallible sentinels?. World J Gastroenterol 2007; 13: 1477–1486
   PubMed Web of Science ®Google Scholar
• Bomsel M., Alfsen A. Entry of viruses through the epithelial barrier: Pathogenic trickery. Nat Rev Mol Cell Biol 2003; 4: 57–68
   PubMed Web of Science ®Google Scholar
• Kunisawa J., Fukuyama S., Kiyono H. Mucosa-associated lymphoid tissues in the aerodigestive tract: Their shared and divergent traits and their importance to the orchestration of the mucosal immune system. Curr Mol Med 2005; 5: 557–572
   PubMed Web of Science ®Google Scholar
• Lekkerkerker A. N., van Kooyk Y., Geijtenbeek T. B. Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res 2006; 4: 169–176
   PubMed Web of Science ®Google Scholar
• Coombes J. L., Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8: 435–446
   PubMed Web of Science ®Google Scholar
• Villablanca E. J., Russo V., Mora J. R. Dendritic cell migration and lymphocyte homing imprinting. Histol Histopathol 2008; 23: 897–910
   Google Scholar
• Carreno M. P., Chomont N., Kazatchkine M. D., Irinopoulou T., Krief C., Mohamed A. S., Andreoletti L., Matta M., Belec L. Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells. J Virol 2002; 76: 32–40
   PubMed Web of Science ®Google Scholar
• Marx P. A., Chen Z. The function of simian chemokine receptors in the replication of SIV. Semin Immunol 1998; 10: 215–223
   Google Scholar
• Moore J. P., Kitchen S. G., Pugach P., Zack J. A. The CCR5 and CXCR4 coreceptors central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20: 111–126
   PubMed Web of Science ®Google Scholar
• Bomsel M., David V. Mucosal gatekeepers: Selecting HIV viruses for early infection. Nat Med 2002; 8: 114–116
   PubMed Web of Science ®Google Scholar
• Meng G., Wei X., Wu X., Sellers M. T., Decker J. M., Moldoveanu Z., Orenstein J. M., Graham M. F., Kappes J. C., Mestecky J., Shaw G. M., Smith P. D. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med 2002; 8: 150–156
   PubMed Web of Science ®Google Scholar
• Cilliers T., Morris L. Coreceptor usage and biological phenotypes of HIV-1 isolates. Clin Chem Lab Med 2002; 40: 911–917
   Google Scholar
• Clapham P. R., McKnight A. Cell surface receptors, virus entry, and tropism of primate lentiviruses. J Gen Virol 2002; 83: 1809–1829
   Google Scholar
• Arthos J., Cicala C., Martinelli E., Macleod K., Van Ryk D., Wei D., Xiao Z., Veenstra T. D., Conrad T. P., Lempicki R. A., McLaughlin S., Pascuccio M., Gopaul R., McNally J., Cruz C. C., Censoplano N., Chung E., Reitano K. N., Kottilil S., Goode D. J., Fauci A. S. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 2008; 9: 301–309
   PubMed Web of Science ®Google Scholar
• Yeaman G. R., Howell A. L., Weldon S., Demian D. J., Collins J. E., O'Connell D. M., Asin S. N., Wira C. R., Fanger M. W. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: Regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003; 109: 137–146
   Google Scholar
• Magerus-Chatinet A., Yu H., Garcia S., Ducloux E., Terris B., Bomsel M. Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells. Virology 2007; 362: 67–74
   PubMed Web of Science ®Google Scholar
• Jameson B., Baribaud F., Pohlmann S., Ghavimi D., Mortari F., Doms R. W., Iwasaki A. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002; 76: 1866–1875
   PubMed Web of Science ®Google Scholar
• Schwartz A. J., Alvarez X., Lackner A. A. Distribution and immunophenotype of DC-SIGN-expressing cells in SIV-infected and uninfected macaques. AIDS Res Hum Retroviruses 2002; 18: 1021–1029
   Google Scholar
• Poonia B., Wang X., Veazey R. S. Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: Implications for virus transmission. J Reprod Immunol 2006; 72: 74–84
   Google Scholar
• Gurney K. B., Elliott J., Nassanian H., Song C., Soilleux E., McGowan I., Anton P. A., Lee B. Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. J Virol 2005; 79: 5762–5773
   PubMed Web of Science ®Google Scholar
• Arrighi J. F., Pion M., Garcia E., Escola J. M., van Kooyk Y., Geijtenbeek T. B., Piguet V. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med 2004; 200: 1279–1288
   PubMed Web of Science ®Google Scholar
• de Witte L., Nabatov A., Geijtenbeek T. B. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med 2008; 14: 12–19
   Google Scholar
• Lambert A. A., Gilbert C., Richard M., Beaulieu A. D., Tremblay M. J. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 2008; 112: 1299–1307
   Google Scholar
• Haase A. T. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005; 5: 783–792
   PubMed Web of Science ®Google Scholar
• Girard M. P., Bansal G. P., Pedroza-Martins L., Dodet B., Mehra V., Schito M., Mathieson B., Delfraissy J. F., Bradac J. Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, October 28–30. Vaccine 2008; 26: 3969–3977
   Google Scholar
• Brenchley J. M., Schacker T. W., Ruff L. E., Price D. A., Taylor J. H., Beilman G. J., Nguyen P. L., Khoruts A., Larson M., Haase A. T., Douek D. C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200: 749–759
   PubMed Web of Science ®Google Scholar
• Mehandru S., Poles M. A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., Boden D., Racz P., Markowitz M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200: 761–770
   PubMed Web of Science ®Google Scholar
• Shattock R. J., Haynes B. F., Pulendran B., Flores J., Esparza J. Improving defenses at the portal of HIV entry: mucosal and innate immunity. PLoS Med 2008; 5: e81
   Google Scholar
• Yuki Y., Nochi T., Kiyono H. Progress towards an AIDS mucosal vaccine: An overview. Tuberculosis (Edinb) 2007; 87(Suppl 1)S35–S44
   Google Scholar
• Vajdy M. Current efforts on generation of optimal immune responses against HIV through mucosal immunisations. Drugs R D 2006; 7: 267–288
   PubMedGoogle Scholar
• Mantis N. J., Palaia J., Hessell A. J., Mehta S., Zhu Z., Corthesy B., Neutra M. R., Burton D. R., Janoff E. N. Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. J Immunol 2007; 179: 3144–3152
   PubMed Web of Science ®Google Scholar
• Gomez-Roman V. R., Patterson L. J., Venzon D., Liewehr D., Aldrich K., Florese R., Robert-Guroff M. Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 2005; 174: 2185–2189
   PubMed Web of Science ®Google Scholar
• Forthal D. N., Gilbert P. B., Landucci G., Phan T. Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. J Immunol 2007; 178: 6596–6603
   PubMed Web of Science ®Google Scholar
• Van Rompay K. K., Berardi C. J., Dillard-Telm S., Tarara R. P., Canfield D. R., Valverde C. R., Montefiori D. C., Cole K. S., Montelaro R. C., Miller C. J., Marthas M. L. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 1998; 177: 1247–1259
   PubMed Web of Science ®Google Scholar
• Hirbod T., Kaul R., Reichard C., Kimani J., Ngugi E., Bwayo J. J., Nagelkerke N., Hasselrot K., Li B., Moses S., MacDonald K. S., Broliden K. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 2008; 22: 727–735
   PubMedGoogle Scholar
• Schmitz J. E., Kuroda M. J., Santra S., Sasseville V. G., Simon M. A., Lifton M. A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B. J., Ghrayeb J., Forman M. A., Montefiori D. C., Rieber E. P., Letvin N. L., Reimann K. A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283: 857–860
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P., Farstad I. N., Haraldsen G. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track. Immunol Today 1999; 20: 267–277
   PubMedGoogle Scholar
• Cesta M. F. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol 2006; 34: 599–608
   PubMed Web of Science ®Google Scholar
• Slutter B., Hagenaars N., Jiskoot W. Rational design of nasal vaccines. J Drug Target 2008; 16: 1–17
   PubMed Web of Science ®Google Scholar
• Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007; 25: 381–418
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25: 5467–5484
   PubMed Web of Science ®Google Scholar
• Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11: S45–S53
   PubMed Web of Science ®Google Scholar
• Vajdy M., Singh M. Intranasal delivery of vaccines against HIV. Expert Opin Drug Deliv 2006; 3: 247–259
   PubMedGoogle Scholar
• Mestecky J., Moldoveanu Z., Russell M. W. Immunologic uniqueness of the genital tract: Challenge for vaccine development. Am J Reprod Immunol 2005; 53: 208–214
   PubMed Web of Science ®Google Scholar
• Couch R. B. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N Engl J Med 2004; 350: 860–861
   PubMed Web of Science ®Google Scholar
• Stowe J., Andrews N., Wise L., Miller E. Bell's palsy and parenteral inactivated influenza vaccine. Hum Vaccin 2006; 2: 110–112
   PubMed Web of Science ®Google Scholar
• Stephenson I., Zambon M. C., Rudin A., Colegate A., Podda A., Bugarini R., Del Giudice G., Minutello A., Bonnington S., Holmgren J., Mills K. H., Nicholson K. G. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants using adult volunteers. J Virol 2006; 80: 4962–4970
   PubMed Web of Science ®Google Scholar
• Caputo A., Brocca-Cofano E., Castaldello A., Voltan R., Gavioli R., Srivastava I. K., Barnett S. W., Cafaro A., Ensoli B. Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin. Vaccine 2008; 26: 1214–1227
   PubMed Web of Science ®Google Scholar
• Barnett S. W., Srivastava I. K., Kan E., Zhou F., Goodsell A., Cristillo A. D., Ferrai M. G., Weiss D. E., Letvin N. L., Montefiori D., Pal R., Vajdy M. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS 2008; 22: 339–348
   PubMed Web of Science ®Google Scholar
• Bielinska A. U., Janczak K. W., Landers J. J., Markovitz D. M., Montefiori D. C., Baker J. R., Jr. Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2008; 24: 271–281
   PubMed Web of Science ®Google Scholar
• Brave A., Hallengard D., Schroder U., Blomberg P., Wahren B., Hinkula J. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses. Vaccine 2008; 26: 5075–5078
   PubMed Web of Science ®Google Scholar
• Bertley F. M., Kozlowski P. A., Wang S. W., Chappelle J., Patel J., Sonuyi O., Mazzara G., Montefiori D., Carville A., Mansfield K. G., Aldovini A. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates. J Immunol 2004; 172: 3745–3757
   PubMed Web of Science ®Google Scholar
• Manrique M., Micewicz E., Kozlowski P. A., Wang S. W., Aurora D., Wilson R. L., Ghebremichael M., Mazzara G., Montefiori D., Carville A., Mansfield K. G., Aldovini A. DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and post-challenge preservation of CD4+ T cell memory. AIDS Res Hum Retroviruses 2008; 24: 505–519
   PubMedGoogle Scholar
• Feng Y., Wang S., Luo F., Ruan Y., Kang L., Xiang X., Chao T., Peng G., Zhu C., Mu Y., Zhu Y., Zhang X., Wu J. A novel recombinant bacterial vaccine strain expressing dual viral antigens induces multiple immune responses to the Gag and gp120 proteins of HIV-1 in immunized mice. Antiviral Res 2008; 80: 272–279
   Google Scholar
• Bienenstock J., McDermott M. R. Bronchus- and nasal-associated lymphoid tissues. Immunol Rev 2005; 206: 22–31
   PubMed Web of Science ®Google Scholar
• Corbett M., Bogers W. M., Heeney J. L., Gerber S., Genin C., Didierlaurent A., Oostermeijer H., Dubbes R., Braskamp G., Lerondel S., Gomez C. E., Esteban M., Wagner R., Kondova I., Mooij P., Balla-Jhagjhoorsingh S., Beenhakker N., Koopman G., van der Burg S., Kraehenbuhl J. P., Le Pape A. Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic. Proc Natl Acad Sci USA 2008; 105: 2046–2051
   PubMed Web of Science ®Google Scholar
• Patterson L. J., Malkevitch N., Venzon D., Pinczewski J., Gomez-Roman V. R., Wang L., Kalyanaraman V. S., Markham P. D., Robey F. A., Robert-Guroff M. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J Virol 2004; 78: 2212–2221
   PubMed Web of Science ®Google Scholar
• Malkevitch N. V., Patterson L. J., Aldrich M. K., Wu Y., Venzon D., Florese R. H., Kalyanaraman V. S., Pal R., Lee E. M., Zhao J., Cristillo A., Robert-Guroff M. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: Role of SIV-specific CD8+ T cell responses. Virology 2006; 353: 83–98
   PubMed Web of Science ®Google Scholar
• Demberg T., Florese R. H., Heath M. J., Larsen K., Kalisz I., Kalyanaraman V. S., Lee E. M., Pal R., Venzon D., Grant R., Patterson L. J., Korioth-Schmitz B., Buzby A., Dombagoda D., Montefiori D. C., Letvin N. L., Cafaro A., Ensoli B., Robert-Guroff M. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) Tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol 2007; 81: 3414–3427
   PubMed Web of Science ®Google Scholar
• Lu F. X., Jacobson R. S. Oral mucosal immunity and HIV/SIV infection. J Dent Res 2007; 86: 216–226
   Google Scholar
• Mercier G. T., Nehete P. N., Passeri M. F., Nehete B. N., Weaver E. A., Templeton N. S., Schluns K., Buchl S. S., Sastry K. J., Barry M. A. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine 2007; 25: 8687–8701
   PubMed Web of Science ®Google Scholar
• Zhou Q., Hidajat R., Peng B., Venzon D., Aldrich M. K., Richardson E., Lee E. M., Kalyanaraman V. S., Grimes G., Gomez-Roman V. R., Summers L. E., Malkevich N., Robert-Guroff M. Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251). Vaccine 2007; 25: 8021–8035
   PubMed Web of Science ®Google Scholar
• Wells J. M., Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol 2008; 6: 349–362
   PubMed Web of Science ®Google Scholar
• Xin K. Q., Hoshino Y., Toda Y., Igimi S., Kojima Y., Jounai N., Ohba K., Kushiro A., Kiwaki M., Hamajima K., Klinman D., Okuda K. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 2003; 102: 223–228
   PubMed Web of Science ®Google Scholar
• Mederle I., Le Grand R., Vaslin B., Badell E., Vingert B., Dormont D., Gicquel B., Winter N. Mucosal administration of three recombinant Mycobacterium bovis BCG-SIVmac251 strains to cynomolgus macaques induces rectal IgAs and boosts systemic cellular immune responses that are primed by intradermal vaccination. Vaccine 2003; 21: 4153–4166
   PubMed Web of Science ®Google Scholar
• Stahl-Hennig C., Kuate S., Franz M., Suh Y. S., Stoiber H., Sauermann U., Tenner-Racz K., Norley S., Park K. S., Sung Y. C., Steinman R., Racz P., Uberla K. Atraumatic oral spray immunization with replication-deficient viral vector vaccines. J Virol 2007; 81: 13180–13190
   Google Scholar
• Breton M., Zhao C., Ouellette M., Tremblay M. J., Papadopoulou B. A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection. J Gen Virol 2007; 88: 217–225
   PubMed Web of Science ®Google Scholar
• Cuburu N., Kweon M. N., Song J. H., Hervouet C., Luci C., Sun J. B., Hofman P., Holmgren J., Anjuere F., Czerkinsky C. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 2007; 25: 8598–8610
   PubMed Web of Science ®Google Scholar
• Song J. H., Nguyen H. H., Cuburu N., Horimoto T., Ko S. Y., Park S. H., Czerkinsky C., Kweon M. N. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci USA 2008; 105: 1644–1649
   PubMed Web of Science ®Google Scholar
• Parez N., Fourgeux C., Mohamed A., Dubuquoy C., Pillot M., Dehee A., Charpilienne A., Poncet D., Schwartz-Cornil I., Garbarg-Chenon A. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J Virol 2006; 80: 1752–1761
   PubMed Web of Science ®Google Scholar
• McConnell E. L., Basit A. W., Murdan S. Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration. Vaccine 2008; 26: 639–646
   PubMed Web of Science ®Google Scholar
• Belyakov I. M., Kuznetsov V. A., Kelsall B., Klinman D., Moniuszko M., Lemon M., Markham P. D., Pal R., Clements J. D., Lewis M. G., Strober W., Franchini G., Berzofsky J. A. Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood 2006; 107: 3258–3264
   PubMed Web of Science ®Google Scholar
• Wang S. W., Bertley F. M., Kozlowski P. A., Herrmann L., Manson K., Mazzara G., Piatak M., Johnson R. P., Carville A., Mansfield K., Aldovini A. An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS. AIDS Res Hum Retroviruses 2004; 20: 846–859
   PubMed Web of Science ®Google Scholar
• Mestecky J. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. J Reprod Immunol 2006; 72: 1–17
   Google Scholar
• Kanazawa T., Takashima Y., Hirayama S., Okada H. Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine. Int J Pharm 2008; 360: 164–170
   PubMed Web of Science ®Google Scholar
• Pialoux G., Hocini H., Perusat S., Silberman B., Salmon-Ceron D., Slama L., Journot V., Mathieu E., Gaillard C., Petitprez K., Launay O., Chene G. Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study. Vaccine 2008; 26: 2657–2666
   PubMed Web of Science ®Google Scholar
• Srivastava I., Goodsell A., Zhou F., Sun Y., Burke B., Barnett S., Vajdy M. Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes. Vaccine 2008; 26: 2796–2806
   Google Scholar
• Vajdy M., Singh M., Kazzaz J., Soenawan E., Ugozzoli M., Zhou F., Srivastava I., Bin Q., Barnett S., Donnelly J., Luciw P., Adamson L., Montefiori D., O'Hagan D. T. Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizations. AIDS Res Hum Retroviruses 2004; 20: 1269–1281
   PubMed Web of Science ®Google Scholar
• Mascola J. R., Stiegler G., VanCott T. C., Katinger H., Carpenter C. B., Hanson C. E., Beary H., Hayes D., Frankel S. S., Birx D. L., Lewis M. G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000; 6: 207–210
   PubMed Web of Science ®Google Scholar
• Kent S. J., Dale C. J., Ranasinghe C., Stratov I., De Rose R., Chea S., Montefiori D. C., Thomson S., Ramshaw I. A., Coupar B. E., Boyle D. B., Law M., Wilson K. M., Ramsay A. J. Mucosally administered human-simian immunodeficiency virus DNA and fowl pox virus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3. Vaccine 2005; 23: 5009–5021
   PubMed Web of Science ®Google Scholar
• Jiang S., Rasmussen R. A., Nolan K. M., Frankel F. R., Lieberman J., McClure H. M., Williams K. M., Babu U. S., Raybourne R. B., Strobert E., Ruprecht R. M. Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys. Vaccine 2007; 25: 7470–7479
   PubMed Web of Science ®Google Scholar
• Hidajat R., Xiao P., Zhou Q., Venzon D., Summers L. E., Kalyanaraman V. S., Montefiori D. C., Robert-Guroff M. Correlation of vaccine-eliicted systemic and mucosal non-neutralizing antibody activities with reduced acute viremia following intrarectal SIVmac251 challenge of rhesus macaques. J. Virol 2009; 83: 791–801
   PubMed Web of Science ®Google Scholar
• Mestecky J., Russell M. W., Elson C. O. Perspectives on mucosal vaccines: Is mucosal tolerance a barrier?. J Immunol 2007; 179: 5633–5638
   PubMed Web of Science ®Google Scholar
• Kraal G., Samsom J. N., Mebius R. E. The importance of regional lymph nodes for mucosal tolerance. Immunol Rev 2006; 213: 119–130
   PubMedGoogle Scholar
• Wu H. Y., Weiner H. L. Oral tolerance. Immunol Res 2003; 28: 265–284
   PubMedGoogle Scholar
• Faria A. M., Weiner H. L. Oral tolerance. Immunol Rev 2005; 206: 232–259
   PubMed Web of Science ®Google Scholar
• Mayer A. K., Dalpke A. H. Regulation of local immunity by airway epithelial cells. Arch Immunol Ther Exp (Warsz) 2007; 55: 353–362
   Google Scholar
• Hippenstiel S., Opitz B., Schmeck B., Suttorp N. Lung epithelium as a sentinel and effector system in pneumonia molecular mechanisms of pathogen recognition and signal transduction. Respir Res 2006; 7: 97
   PubMed Web of Science ®Google Scholar
• Montufar-Solis D., Garza T., Klein J. R. T-cell activation in the intestinal mucosa. Immunol Rev 2007; 215: 189–201
   Google Scholar
• Johansson-Lindbom B., Agace W. W. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol Rev 2007; 215: 226–242
   PubMed Web of Science ®Google Scholar
• Mora J. R. Homing imprinting and immunomodulation in the gut: Role of dendritic cells and retinoids. Inflamm Bowel Dis 2008; 14: 275–289
   PubMed Web of Science ®Google Scholar
• Mora J. R., Iwata M., Eksteen B., Song S. Y., Junt T., Senman B., Otipoby K. L., Yokota A., Takeuchi H., Ricciardi-Castagnoli P., Rajewsky K., Adams D. H., von Andrian U. H. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006; 314: 1157–1160
   PubMed Web of Science ®Google Scholar
• Mora J. R., von Andrian U. H. T-cell homing specificity and plasticity: New concepts and future challenges. Trends Immunol 2006; 27: 235–243
   PubMed Web of Science ®Google Scholar
• Mora J. R., Cheng G., Picarella D., Briskin M., Buchanan N., von Andrian U. H. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J Exp Med 2005; 201: 303–316
   PubMed Web of Science ®Google Scholar
• Greenland J. R., Letvin N. L. Chemical adjuvants for plasmid DNA vaccines. Vaccine 2007; 25: 3731–3741
   PubMed Web of Science ®Google Scholar
• Goodsell A., Zhou F., Gupta S., Singh M., Malyala P., Kazzaz J., Greer C., Legg H., Tang T., Zur Megede J., Srivastava R., Barnett S. W., Donnelly J. J., Luciw P. A., Polo J., O'Hagan D. T., Vajdy M. Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery. Immunology 2008; 123: 378–389
   PubMed Web of Science ®Google Scholar
• Iqbal S. M., Kaul R. Mucosal innate immunity as a determinant of HIV susceptibility. Am J Reprod Immunol 2008; 59: 44–54
   Web of Science ®Google Scholar
• Furci L., Sironi F., Tolazzi M., Vassena L., Lusso P. Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood 2007; 109: 2928–2935
   Web of Science ®Google Scholar
• Schneider J. A., Alam S. A., Ackers M., Parekh B., Chen H. Y., Graham P., Gurwith M., Mayer K., Novak R. M. Mucosal HIV-binding antibody and neutralizing activity in high-risk HIV-uninfected female participants in a trial of HIV-vaccine efficacy. J Infect Dis 2007; 196: 1637–1644
   PubMedGoogle Scholar
• Cleghorn F., Pape J. W., Schechter M., Bartholomew C., Sanchez J., Jack N., Metch B. J., Hansen M., Allen M., Cao H., Montefiori D. C., Tomaras G. D., Gurunathan S., Eastman D. J., do Lago R. F., Jean S., Lama J. R., Lawrence D. N., Wright P. F. Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120. J Acquir Immune Defic Syn 2007; 46: 222–230
   PubMed Web of Science ®Google Scholar
• Sheppard N. C., Bates A. C., Sattentau Q. J. A functional human IgM response to HIV-1 Env after immunization with NYVAC HIV C. AIDS 2007; 21: 524–527
   PubMedGoogle Scholar
• Jaoko W., Nakwagala F. N., Anzala O., Manyonyi G. O., Birungi J., Nanvubya A., Bashir F., Bhatt K., Ogutu H., Wakasiaka S., Matu L., Waruingi W., Odada J., Oyaro M., Indangasi J., Ndinya-Achola J., Konde C., Mugisha E., Fast P., Schmidt C., Gilmour J., Tarragona T., Smith C., Barin B., Dally L., Johnson B., Muluubya A., Nielsen L., Hayes P., Boaz M., Hughes P., Hanke T., McMichael A., Bwayo J., Kaleebu P. Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. Vaccine 2008; 26: 2788–2795
   PubMed Web of Science ®Google Scholar
• Sekal R. P. The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?. J Exp Med 2008; 205: 7–12
   Google Scholar
• Malkevitch N. V., Robert-Guroff M. A call for replicating vector prime-protein boost strategies in HIV vaccine design. Expert Rev Vaccines 2004; 3: S105–S117
   Google Scholar
• Gaydos C. A., Gaydos J. C. Adenovirus vaccines in the U. S. military. Mil Med 1995; 160: 300–304
   PubMed Web of Science ®Google Scholar
• Santosuosso M., McCormick S., Xing Z. Adenoviral vectors for mucosal vaccination against infectious diseases. Viral Immunol 2005; 18: 283–291
   PubMed Web of Science ®Google Scholar
• Robert-Guroff M. Replicating and non-replicating viral vectors for vaccine development. Curr Opin Biotechnol 2007; 18: 546–556
   PubMed Web of Science ®Google Scholar
• Patterson L. J., Robert-Guroff M. Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development. Expert Opin Biol Ther 2008; 8: 1347–1363
   PubMed Web of Science ®Google Scholar
• Wright P. F., Kozlowski P. A., Rybczyk G. K., Goepfert P., Staats H. F., VanCott T. C., Trabattoni D., Sannella E., Mestecky J. Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses 2002; 18: 1291–1300
   PubMedGoogle Scholar
• Bono M. R., Elgueta R., Sauma D., Pino K., Osorio F., Michea P., Fierro A., Rosemblatt M. The essential role of chemokines in the selective regulation of lymphocyte homing. Cytokine Growth Factor Rev 2007; 18: 33–43
   Google Scholar
• Marelli-Berg F. M., Cannella L., Dazzi F., Mirenda V. The highway code of T cell trafficking. J Pathol 2008; 214: 179–189
   Google Scholar
• Chen D., Bromberg J. S. T regulatory cells and migration. Am J Transplant 2006; 6: 1518–1523
   PubMed Web of Science ®Google Scholar
• Viola A., Molon B., Contento R. L. Chemokines: Coded messages for T-cell missions. Front Biosci 2008; 13: 6341–6353
   Google Scholar
• Huehn J., Hamann A. Homing to suppress: Address codes for Treg migration. Trends Immunol 2005; 26: 632–636
   PubMed Web of Science ®Google Scholar
• Bromley S. K., Mempel T. R., Luster A. D. Orchestrating the orchestrators: Chemokines in control of T cell traffic. Nat Immunol 2008; 9: 970–980
   PubMed Web of Science ®Google Scholar
• Thomas S. Y., Banerji A., Medoff B. D., Lilly C. M., Luster A. D. Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway. J Immunol 2007; 179: 1901–1912
   PubMed Web of Science ®Google Scholar
• Agostini C., Calabrese F., Poletti V., Marcer G., Facco M., Miorin M., Cabrelle A., Baesso I., Zambello R., Trentin L., Semenzato G. CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis. Respir Res 2005; 6: 20
   Google Scholar
• Ebert L. M., Schaerli P., Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005; 42: 799–809
   PubMed Web of Science ®Google Scholar
• Burger J. A., Burkle A. The CXCR4 chemokine receptor in acute and chronic leukaemia: A marrow homing receptor and potential therapeutic target. Br J Haematol 2007; 137: 288–296
   PubMed Web of Science ®Google Scholar
• Aust G., Sittig D., Becherer L., Anderegg U., Schutz A., Lamesch P., Schmucking E. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur J Endocrinol 2004; 150: 225–234
   PubMed Web of Science ®Google Scholar
• Agostini C., Cabrelle A., Calabrese F., Bortoli M., Scquizzato E., Carraro S., Miorin M., Beghe B., Trentin L., Zambello R., Facco M., Semenzato G. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med 2005; 172: 1290–1298
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez E. V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639–646
   PubMed Web of Science ®Google Scholar